Artificial intelligence extension of the OSCAR‐IB criteria. Issue 7 (19th May 2021)

• Record Type: Journal Article
• Authors: Petzold, Axel; Albrecht, Philipp; Balcer, Laura; Bekkers, Erik; Brandt, Alexander U.; Calabresi, Peter A.; Deborah, Orla Galvin; Graves, Jennifer S.; Green, Ari; Keane, Pearse A; Nij Bijvank, Jenny A.; Sander, Josemir W.; Paul, Friedemann; Saidha, Shiv; Villoslada, Pablo; Wagner, Siegfried K; Yeh, E. Ann
• Other Names: Aktas Orhan investigator.; Antel Jack investigator.; Asgari Nasrin investigator.; Audo Isabelle investigator.; Avasarala Jagannadha investigator.; Avril Daly investigator.; Bagnato Francesca R investigator.; Banwell Brenda investigator.; Bar‐Or Amit investigator.; Behbehani Raed investigator.; Manterola Arnaldo Belzunce investigator.; Bennett Jeffrey investigator.; Benson Leslie investigator.; Bernard Jacqueline investigator.; Bremond‐Gignac Dominique investigator.; Britze Josefine investigator.; Burton Jodie investigator.; Calkwood Jonathan investigator.; Carroll William investigator.; Chandratheva Arvind investigator.; Cohen Jeffrey investigator.; Comi Giancarlo investigator.; Cordano Christian investigator.; Costa Silvana investigator.; Costello Fiona investigator.; Courtney Ardith investigator.; Cruz‐Herranz Anes investigator.; Cutter Gary investigator.; Crabb David investigator.; Delott Lindsey investigator.; De Seze Jerome investigator.; Diem Ricarda investigator.; Dollfuss Helene investigator.; El Ayoubi Nabil K investigator.; Fasser Christina investigator.; Finke Carsten investigator.; Fischer Dominik investigator.; Fitzgerald Kathryn investigator.; Fonseca Pedro investigator.; Frederiksen Jette L investigator.; Frohman Elliot investigator.; Frohman Teresa investigator.; Fujihara Kazuo investigator.; Cuellar Iñigo Gabilondo investigator.; Galetta Steven investigator.; Garcia‐Martin Elena investigator.; Giovannoni Gavin investigator.; Glebauskiene Brigita investigator.; Suárez Inés González investigator.; Jensen, Gorm Pihl investigator.; Hamann Steffen investigator.; Hartung Hans‐Peter investigator.; Havla Joachim investigator.; Hemmer Bernhard investigator.; Huang Su‐Chun investigator.; Imitola Jaime investigator.; Jasinskas Vytautas investigator.; Jiang Hong investigator.; Kafieh Rahele investigator.; Kappos Ludwig investigator.; Kardon Randy investigator.; Keegan David investigator.; Kildebeck Eric investigator.; Kim Ungsoo Samuel investigator.; Klistorner Sasha investigator.; Knier Benjamin investigator.; Kolbe Scott investigator.; Korn Thomas investigator.; Krupp Lauren investigator.; Lagrèze Wolf investigator.; Leocani Letizia investigator.; Levin Netta investigator.; Liskova Petra investigator.; Preiningerova Jana Lizrova investigator.; Lorenz Birgit investigator.; May Eugene investigator.; Miller David investigator.; Mikolajczak Janine investigator.; Saïd Saddek Mohand investigator.; Montalban Xavier investigator.; Morrow Mark investigator.; Mowry Ellen investigator.; Murta Joaquim investigator.; Navas Carlos investigator.; Nolan Rachel investigator.; Nowomiejska Katarzyna investigator.; Oertel Frederike Cosima investigator.; Oh Jiwon investigator.; Oreja‐Guevara Celia investigator.; Orssaud Christophe investigator.; Osborne Benjamin investigator.; Outteryck Olivier investigator.; Paiva Catarina investigator.; Palace Jacky investigator.; Papadopoulou Athina investigator.; Patsopoulos Nikos investigator.; Preiningerova Jana Lizrova investigator.; Pontikos Nikolas investigator.; Preising Markus investigator.; Prince Jerry investigator.; Reich Daniel investigator.; Rejdak Robert investigator.; Ringelstein Marius investigator.; Rodriguez de Antonio Luis investigator.; Sahel Jose‐Alain investigator.; Sanchez‐Dalmau Bernardo investigator.; Sastre‐Garriga Jaume investigator.; Schippling Sven investigator.; Schuman Joel investigator.; Shindler Ken investigator.; Shin Robert investigator.; Shuey Neil investigator.; Soelberg Kerstin investigator.; Specovius Svenja investigator.; Suppiej Agnese investigator.; Thompson Alan investigator.; Toosy Ahmed investigator.; Torres Rubén investigator.; Touitou Valérie investigator.; Trauzettel‐Klosinski Susanne investigator.; van der Walt Anneke investigator.; Vermersch Patrick investigator.; Vidal‐Jordana Angela investigator.; Waldman Amy T investigator.; Waters Christian investigator.; Wheeler Russell investigator.; White Owen investigator.; Wilhelm Helmut investigator.; Winges Kimberly M investigator.; Wiegerinck Nils investigator.; Wiehe Lenja investigator.; Wisnewski Thomas investigator.; Wong Sui investigator.; Würfel Jens investigator.; Yaghi Shadi investigator.; You Yuyi investigator.; Yu Zhaoxia investigator.; Yu‐Wai‐Man Patrick investigator.; Žemaitien≐ Reda investigator.; Zimmermann Hanna investigator.;
• Is Part Of: Annals of clinical and translational neurology. Volume 8:Issue 7(2021)
• Page Start: 1528
• Page End: 1542
• Publication Date: 2021-05-19
• Subjects: Nervous system -- Diseases -- Periodicals; Neurology -- Periodicals; 616.8005
• DOI: 10.1002/acn3.51320
• Languages: English
• ISSNs: 2328-9503

Abstract

Abstract: Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big data in neurology is optical coherence tomography (OCT). We highlight that OCT changes observed in the retina, as a window to the brain, are small, requiring rigorous quality control pipelines. There are existing tools for this purpose. Firstly, there are human‐led validated consensus quality control criteria (OSCAR‐IB) for OCT. Secondly, these criteria are embedded into OCT reporting guidelines (APOSTEL). The use of the described annotation of failed OCT scans advances machine learning. This is illustrated through the present review of the advantages and disadvantages of AI‐based applications to OCT data. The neurological conditions reviewed here for the use of big data include Alzheimer disease, stroke, multiple sclerosis (MS), Parkinson disease, and epilepsy. It is noted that while big data is relevant for AI, ownership is complex. For this reason, we also reached out to involve representatives from patient organizations and the public domain in addition to clinical and research centers. The evidence reviewed can be grouped in a five‐point expansion of the OSCAR‐IB criteria to embrace AI (OSCAR‐AI). The review concludes by specific recommendations on how this can be achieved practically and in compliance with existing guidelines.